JP2018501241A5 - - Google Patents

Download PDF

Info

Publication number
JP2018501241A5
JP2018501241A5 JP2017532859A JP2017532859A JP2018501241A5 JP 2018501241 A5 JP2018501241 A5 JP 2018501241A5 JP 2017532859 A JP2017532859 A JP 2017532859A JP 2017532859 A JP2017532859 A JP 2017532859A JP 2018501241 A5 JP2018501241 A5 JP 2018501241A5
Authority
JP
Japan
Prior art keywords
composition
subject
use according
derived
msc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017532859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018501241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2015/000755 external-priority patent/WO2016094932A1/en
Publication of JP2018501241A publication Critical patent/JP2018501241A/ja
Publication of JP2018501241A5 publication Critical patent/JP2018501241A5/ja
Priority to JP2022035174A priority Critical patent/JP2022069524A/ja
Pending legal-status Critical Current

Links

JP2017532859A 2014-12-19 2015-12-18 改良された細胞療法 Pending JP2018501241A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022035174A JP2022069524A (ja) 2014-12-19 2022-03-08 改良された細胞療法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU2014905156 2014-12-19
AU2014905157A AU2014905157A0 (en) 2014-12-19 Improved cell-based therapies
AU2014905157 2014-12-19
AU2014905156A AU2014905156A0 (en) 2014-12-19 Improved cell therapies
AU2015901929 2015-05-26
AU2015901929A AU2015901929A0 (en) 2015-05-26 Improved cell therapies
PCT/AU2015/000755 WO2016094932A1 (en) 2014-12-19 2015-12-18 Improved cell therapies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022035174A Division JP2022069524A (ja) 2014-12-19 2022-03-08 改良された細胞療法

Publications (2)

Publication Number Publication Date
JP2018501241A JP2018501241A (ja) 2018-01-18
JP2018501241A5 true JP2018501241A5 (https=) 2019-02-07

Family

ID=56125431

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017532859A Pending JP2018501241A (ja) 2014-12-19 2015-12-18 改良された細胞療法
JP2022035174A Pending JP2022069524A (ja) 2014-12-19 2022-03-08 改良された細胞療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022035174A Pending JP2022069524A (ja) 2014-12-19 2022-03-08 改良された細胞療法

Country Status (5)

Country Link
US (1) US20180221411A1 (https=)
EP (1) EP3233097A4 (https=)
JP (2) JP2018501241A (https=)
AU (1) AU2015367275B2 (https=)
WO (1) WO2016094932A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200171092A1 (en) * 2017-06-09 2020-06-04 Osaka University Therapeutic agent for dilated cardiomyopathy
CA3074470C (en) * 2017-09-15 2024-01-16 Cynata Therapeutics Limited Method for treating allergic airways disease (aad)/ asthma
US10702547B2 (en) * 2018-05-16 2020-07-07 Aq Skin Solutions Inc. Compositions for treatment of arthritis
MA52883A (fr) * 2018-06-15 2021-05-26 Prieto Manuel Hermida Composition pharmaceutique pour dermatologie et ses utilisations
US20230022259A1 (en) * 2021-07-08 2023-01-26 Boehringer Ingelheim Veterinary Medicine Belgium Mesenchymal stem cells for use in the treatment of osteoarthritis in animals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013205141A1 (en) * 2008-08-22 2013-05-16 Regeneus Ltd. Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes
AU2010347212B2 (en) 2010-09-14 2016-07-14 Cell Ideas Pty Ltd Cell free preparation and uses thereof
WO2012106367A2 (en) * 2011-01-31 2012-08-09 Royal Daniel F Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
DK2744892T3 (en) * 2011-09-23 2019-04-23 Cell Ideas Pty Ltd THERAPEUTICS USING FAT CELLS AND CELL SECRETIONS
US9782440B2 (en) * 2012-02-16 2017-10-10 The Cleveland Clinic Foundation Methods for treating genitourinary disorders

Similar Documents

Publication Publication Date Title
Gugjoo et al. Equine mesenchymal stem cells: properties, sources, characterization, and potential therapeutic applications
Markoski Advances in the use of stem cells in veterinary medicine: from basic research to clinical practice
Matsuura et al. Cell sheet approach for tissue engineering and regenerative medicine
De Schauwer et al. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?
JP2018501241A5 (https=)
Hall et al. Early embryonic development, assisted reproductive technologies, and pluripotent stem cell biology in domestic mammals
PE20250757A1 (es) Muteinas de interleucina 21 y metodos de tratamiento
CL2011001984A1 (es) Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora.
JP2014527821A5 (https=)
MX2020005849A (es) Células madre y progenitoras hematopoyéticas humanas cd34+ modificadas con crispr-cas9 y sus usos.
BR112013028257A2 (pt) "composição de fármaco biológico, métodos de manipulação de uma composição de fármaco biológica com células vivas e de fornecer composições de células vivas em um ponto de instalação de tratamento, bem como uso de células vivas formuladas em tampão não nutritivo"
MX385015B (es) Suplemento alimenticio.
ES3060533T3 (en) Cell suspension and use thereof
GB2562406A (en) A method of non destructive monitoring of biological processes in microfluidic tissue culture systems
EP3943092A3 (en) Compositions for use in inducing differentiation of human brown adipocyte progenitors
JP2015205894A5 (https=)
MX2019014578A (es) Celulas renales bioactivas inmunoprivilegiadas para el tratamiento de enfermedad renal.
BR112016002385A2 (pt) animal não humano, célula, tecido ou embrião, vetor de alvejamento, constructo de vetor de alvejamento, e, métodos para produzir um animal não humano e para modificar um lócus de incrna em uma célula pluripotente
EA201890856A1 (ru) Улучшенные транспортные молекулы модулярного антигена и их применение у животных
Svoradova et al. Chicken mesenchymal stem cells and their applications: a mini review
Leal Reis et al. Allogenic synovia-derived mesenchymal stem cells for treatment of equine tendinopathies and Desmopathies—proof of concept
Yushkov et al. Stem-cell niches in health and disease: microenvironmental determinants of regeneration and pathology
Yadav et al. Fetal stem cells in farm animals: applications in health and production
Zakirova et al. Case of applying allogenic mesenchymal stem cells of adipogenic origin in veterinary dentistry
Azargoon et al. Lung regeneration using amniotic fluid mesenchymal stem cells